MediCool Technologies, Inc.

MediCool is developing a painless way to treat dangerous cardiac arrhythmias and other disorders.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location Traverse City, MI, USA
  • Currency USD
  • Founded August 2015
  • Employees 10
  • Incorporation Type C-corp
  • Website medicooltech.com

Company Summary

MediCool is developing a novel painless therapy for dangerous cardiac arrhythmias. We are initially focused on Post-operative A-Fib (POAF) a common, expensive and potentially morbid complication following cardiac surgery. MediCool’s approach, which has been successfully demonstrated in pre-clinical and First In Human trials, uses a cooling implant to painlessly terminate episodes of POAF while the patient is recovering from cardiac surgery.

Team

  • President & Chief Executive Officer

    Proven commercial leader with over 20 years experience in CRM and A-Fib markets including 15 years at Boston Scientific and Guidant.
    Commercialized multiple new devices and therapies.

  • Chief Financial Officer

    18 years of corporate finance and investment banking experience at Morgan Stanley, Wells Fargo and BNP Paribas
    Advised 40+ M&A deals and led IPOs in excess of $15B

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free